AGI-5198 treatment of mice engrafted with IDH1-mutant glioma removed repressive marks via significant reduction of H3K9 and H3K27 trimethylation at the promoters of genes associated with gliogenic (astrocytic and oligodendrocytic) differentiation, increasing the expression of these genes [74]. The gene discussed is IDH1; the disease is central nervous system cancer.